DNLIDenali Therapeutics Inc.

$24.58

Is the business good?

How good a business is DNLI?

Share count, year on year
+9.3%

Share count, year on year · shareholders own a smaller slice than a year ago

Operating margin by fiscal year
YearOperating margin
FY202019%
FY2021−608%
FY2022−314%
FY2023−60%
Details
Free cash flow, trailing twelve months
−$440M
Net income, trailing twelve months
−$511M

Margins, capital and share counts from the statements as filed with the SEC; cash conversion from the cash flow statement.